blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3326458

EP3326458 - RODENTS WITH CONDITIONAL ACVR1 MUTANT ALLELES [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  16.04.2021
Database last updated on 12.08.2024
FormerThe patent has been granted
Status updated on  08.05.2020
FormerGrant of patent is intended
Status updated on  09.01.2020
FormerExamination is in progress
Status updated on  25.06.2019
FormerRequest for examination was made
Status updated on  07.12.2018
FormerThe application has been published
Status updated on  27.04.2018
Most recent event   Tooltip03.05.2024Lapse of the patent in a contracting state
New state(s): MK		published on 05.06.2024  [2024/23]
Applicant(s)For all designated states
Regeneron Pharmaceuticals, Inc.
777 Old Saw Mill River Road
Tarrytown, NY 10591-6707 / US
[2018/22]
Inventor(s)01 / ECONOMIDES, Aris N.
574 Bedford Road
Tarrytown, NY 10591 / US
02 / HATSELL, Sarah Jane
48 Summit Street
Nyack, NY 10960 / US
 [2018/22]
Representative(s)J A Kemp LLP
80 Turnmill Street
London EC1M 5QU / GB
[N/P]
Former [2020/24]J A Kemp LLP
14 South Square
Gray's Inn
London WC1R 5JJ / GB
Former [2018/22]J A Kemp
14 South Square
Gray's Inn
London WC1R 5JJ / GB
Application number, filing date18150822.713.03.2014
[2018/22]
Priority number, dateUS201361778814P13.03.2013         Original published format: US 201361778814 P
[2018/22]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP3326458
Date:30.05.2018
Language:EN
[2018/22]
Type: B1 Patent specification 
No.:EP3326458
Date:10.06.2020
Language:EN
[2020/24]
Search report(s)(Supplementary) European search report - dispatched on:EP26.03.2018
ClassificationIPC:A01K67/027, C12N15/85
[2018/22]
CPC:
A01K67/0275 (EP,RU,US); C07K14/71 (EP,US); A01K2217/072 (EP,US);
A01K2217/203 (EP,US); A01K2227/105 (EP,US); A01K2267/0306 (EP,US);
C12N2015/8536 (US); C12N2800/30 (EP,US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2019/02]
Former [2018/22]AL,  AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MK,  MT,  NL,  NO,  PL,  PT,  RO,  RS,  SE,  SI,  SK,  SM,  TR 
TitleGerman:NAGETIERE MIT BEDINGTEN ACVR1-MUTIERTEN ALLELEN[2018/22]
English:RODENTS WITH CONDITIONAL ACVR1 MUTANT ALLELES[2018/22]
French:RONGEURS À ALLÈLES MUTANTS ACVR1 CONDITIONNELS[2018/22]
Examination procedure29.11.2018Amendment by applicant (claims and/or description)
29.11.2018Examination requested  [2019/02]
29.11.2018Date on which the examining division has become responsible
28.06.2019Despatch of a communication from the examining division (Time limit: M04)
31.10.2019Reply to a communication from the examining division
10.01.2020Communication of intention to grant the patent
29.04.2020Fee for grant paid
29.04.2020Fee for publishing/printing paid
29.04.2020Receipt of the translation of the claim(s)
Parent application(s)   TooltipEP14722437.2  / EP2967016
Opposition(s)11.03.2021No opposition filed within time limit [2021/20]
Fees paidRenewal fee
09.01.2018Renewal fee patent year 03
09.01.2018Renewal fee patent year 04
09.01.2018Renewal fee patent year 05
22.03.2019Renewal fee patent year 06
20.03.2020Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU13.03.2014
AL10.06.2020
AT10.06.2020
CY10.06.2020
CZ10.06.2020
DK10.06.2020
EE10.06.2020
HR10.06.2020
LT10.06.2020
LV10.06.2020
MC10.06.2020
MK10.06.2020
NL10.06.2020
PL10.06.2020
RO10.06.2020
RS10.06.2020
SI10.06.2020
SK10.06.2020
SM10.06.2020
BG10.09.2020
NO10.09.2020
GR11.09.2020
IS10.10.2020
PT12.10.2020
[2024/23]
Former [2023/33]HU13.03.2014
AL10.06.2020
AT10.06.2020
CY10.06.2020
CZ10.06.2020
DK10.06.2020
EE10.06.2020
HR10.06.2020
LT10.06.2020
LV10.06.2020
MC10.06.2020
NL10.06.2020
PL10.06.2020
RO10.06.2020
RS10.06.2020
SI10.06.2020
SK10.06.2020
SM10.06.2020
BG10.09.2020
NO10.09.2020
GR11.09.2020
IS10.10.2020
PT12.10.2020
Former [2023/30]AL10.06.2020
AT10.06.2020
CY10.06.2020
CZ10.06.2020
DK10.06.2020
EE10.06.2020
HR10.06.2020
LT10.06.2020
LV10.06.2020
MC10.06.2020
NL10.06.2020
PL10.06.2020
RO10.06.2020
RS10.06.2020
SI10.06.2020
SK10.06.2020
SM10.06.2020
BG10.09.2020
NO10.09.2020
GR11.09.2020
IS10.10.2020
PT12.10.2020
Former [2021/45]AL10.06.2020
AT10.06.2020
CZ10.06.2020
DK10.06.2020
EE10.06.2020
HR10.06.2020
LT10.06.2020
LV10.06.2020
MC10.06.2020
NL10.06.2020
PL10.06.2020
RO10.06.2020
RS10.06.2020
SI10.06.2020
SK10.06.2020
SM10.06.2020
BG10.09.2020
NO10.09.2020
GR11.09.2020
IS10.10.2020
PT12.10.2020
Former [2021/24]AL10.06.2020
AT10.06.2020
CZ10.06.2020
DK10.06.2020
EE10.06.2020
HR10.06.2020
LT10.06.2020
LV10.06.2020
NL10.06.2020
PL10.06.2020
RO10.06.2020
RS10.06.2020
SI10.06.2020
SK10.06.2020
SM10.06.2020
BG10.09.2020
NO10.09.2020
GR11.09.2020
IS10.10.2020
PT12.10.2020
Former [2021/21]AL10.06.2020
AT10.06.2020
CZ10.06.2020
DK10.06.2020
EE10.06.2020
HR10.06.2020
LT10.06.2020
LV10.06.2020
NL10.06.2020
PL10.06.2020
RO10.06.2020
RS10.06.2020
SK10.06.2020
SM10.06.2020
BG10.09.2020
NO10.09.2020
GR11.09.2020
IS10.10.2020
PT12.10.2020
Former [2021/10]AL10.06.2020
AT10.06.2020
CZ10.06.2020
EE10.06.2020
HR10.06.2020
LT10.06.2020
LV10.06.2020
NL10.06.2020
PL10.06.2020
RO10.06.2020
RS10.06.2020
SK10.06.2020
SM10.06.2020
BG10.09.2020
NO10.09.2020
GR11.09.2020
IS10.10.2020
PT12.10.2020
Former [2021/09]AL10.06.2020
AT10.06.2020
CZ10.06.2020
EE10.06.2020
HR10.06.2020
LT10.06.2020
LV10.06.2020
NL10.06.2020
RO10.06.2020
RS10.06.2020
SM10.06.2020
BG10.09.2020
NO10.09.2020
GR11.09.2020
PT12.10.2020
Former [2021/04]AL10.06.2020
HR10.06.2020
LT10.06.2020
LV10.06.2020
NL10.06.2020
RS10.06.2020
BG10.09.2020
NO10.09.2020
GR11.09.2020
Former [2021/01]HR10.06.2020
LT10.06.2020
LV10.06.2020
RS10.06.2020
BG10.09.2020
NO10.09.2020
GR11.09.2020
Former [2020/51]HR10.06.2020
LT10.06.2020
LV10.06.2020
RS10.06.2020
NO10.09.2020
GR11.09.2020
Former [2020/50]HR10.06.2020
LT10.06.2020
LV10.06.2020
NO10.09.2020
GR11.09.2020
Former [2020/47]LT10.06.2020
NO10.09.2020
Documents cited:Search[A]WO02088353  (ADEREGEM [FR], et al);
 [A]WO2007123896  (UNIV PENNSYLVANIA [US], et al);
 [A]WO2011059799  (REGENERON PHARMA [US], et al);
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.